Intelligent defect recognition
All of Gerresheimer’s tubular glass plants work with standardized moni-toring, inspection, and packaging technologies, which essentially com-prise the Gx G3 and Gx RHOC systems. The inspection systems, for one, are developed in house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably, for in-stance. The intelligent software detects and classifies the defects in a few fractions of a second, while the Gx RHOC system ensures dimen-sional quality with three HD matrix cameras on each side and a hyper-centric ID camera. Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s come in all sizes and comply with the relevant international standards and pharmacopeias. The company’s range in-cludes solutions for bioengineered drugs and other specialist pharmaceu-ticals.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contrib-utes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bot-tles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.